Austin, TX 11/6/2007 12:10:56 AM
Speak with other shareholders about: (OTCBB: WSEG), (NASDAQ: BNVI), (OTCBB: OLGX), (NYSE: SRI).
Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the “Chat Live” button at the top.
----------------------------------------------------------
Chat real-time with other investors about this WSEG news release, by
clicking this link: http://www.stockwire.com/WSEG
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=WSEG
Western Standard Energy Corp. (OTCBB: WSEG) Current Price (.50).
LONDON--Nov.1--Western Standard Energy Corp.,(NASD OTC BB:WSEG), an oil and gas exploration company, today announced that it has entered into a Memorandum of Understanding (MOI) with Oil For America LLC to acquire 2 leases in the Lodgepole Reef Prospects in Stark County, North Dakota. Under the terms of the MOI, signed September 25, 2007, Western Standard will acquire 2 Lodgepole Reef Prospects. In the event that Western Standard drills both prospects, Oil For America agrees to identify and high grade an additional 8 Lodgepole Reef prospects for Western Standard on the same terms.
Western Standard Energy Corp. is a publicly traded independent oil and gas exploration company with headquarters in London, England. Currently, Western Standard has a Farmout Agreement with Coastal Petroleum Company, for leases on approximately forty-two thousand (42,000) acres in Valley County Shallow Gas Assembly in the state of Montana. Western Standard aims to secure and develop a portfolio of oil and gas properties throughout the Central and Western United States of America. Western Standard Energy Corp. is a publicly traded company and trades on the NASD OTC BB under the ticker symbol: WSEG.
----------------------------------------------------------
Chat real-time with other investors about this BNVI news release, by
clicking this link: http://www.stockwire.com/BNVI
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=BNVI
Bionovo, Inc. (NASDAQ: BNVI) Current Price (2.33).
EMERYVILLE, Calif., Nov. 1-- Bionovo, Inc. (NASDAQ: BNVI), a leader in the discovery and development of safe and effective drugs in the areas of women's health and cancer, is scheduled to present at the 9th Annual Acumen BioFin Rodman and Renshaw Healthcare Conference in New York. The presentation by Tom Chesterman, SVP and CFO of Bionovo, Inc., will take place on November 6, 2007 at 4:45 p.m. local time at the New York Palace Hotel in New York City. Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit http://www.bionovo.com.
----------------------------------------------------------
Chat real-time with other investors about this OLGX news release, by
clicking this link: http://www.stockwire.com/OLGX
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=OLGX
Osteologix Inc. (OTCBB: OLGX) Current Price (1.50).
SAN FRANCISCO--Nov.1--Osteologix Inc. (OTCBB: OLGX), a specialty pharmaceutical company, today announced that Malene Weis M.SC.Pharm., Director of Clinical Development of Osteologix, will give a presentation entitled "Challenges for Small Pharma in Setting up and Managing a Clinical Trial" during a Symposium regarding outsourcing challenges for small pharma and biotech at the 6th Annual Partnerships in Clinical Trials Congress and Exhibition 2007 on Monday, November 5, 2007 in Amsterdam RAI, The Netherlands. Following her presentation, Weis will participate as a panel member during the Discussion Session entitled "Developing an Outsourcing Strategy that Keeps Pace with Your Company's Growth". Weis has worked with all stages of clinical development at both pharmaceutical companies and contract research organizations (CROs). She has held prime responsibility for the design and operational execution of numerous clinical trials within various therapeutic areas, including Osteologix's latest Phase II STRONG Study of the company's lead drug candidate for the treatment and prevention of osteoporosis, NB S101. The data for the STRONG Study will be released in the 4th quarter of 2007. Osteologix is a specialty pharmaceutical company committed to developing innovative therapies for the treatment and prevention of musculoskeletal diseases. The Company's vision is to improve the health of those afflicted with musculoskeletal diseases such as osteoporosis. Its lead product candidate, NB S101, is a novel pharmaceutical agent for the treatment and prevention of osteoporosis. For more information please visit www.osteologix.com.
----------------------------------------------------------
Chat real-time with other investors about this SRI news release, by
clicking this link: http://www.stockwire.com/SRI
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=SRI
Stoneridge Inc. (NYSE: SRI) Current Price (10.16).
WARREN, Ohio, Nov. 2 -- Stoneridge, Inc. (NYSE: SRI) today announced net sales of $172.8 million and net income of $2.6 million, or $0.11 per diluted share, for the third quarter ended September 30, 2007. Stoneridge, Inc. engages in the design and manufacture of engineered electrical and electronic components, modules, and systems for the automotive, medium and heavy-duty truck, and agricultural and off-highway vehicle markets primarily in North America and Europe. The company operates in two segments, Vehicle Management and Power Distribution, and Control Devices. The Vehicle Management and Power Distribution segment produces electronic instrument clusters, electronic control units, and electrical distribution systems, primarily wiring harnesses and connectors for electrical power and signal distribution. These products collect, store, and display vehicle information, such as speed, pressure, maintenance data, trip information, operator performance, temperature, distance traveled, and driver messages related to vehicle performance. In addition, power distribution systems regulate, co-ordinate, and direct the operation of the electrical system within a vehicle compartment. The Control Devices segment produces products that include sensors, which are employed in various vehicle systems, including the emissions, safety, powertrain, braking, climate control, steering, and suspension systems; switches that transmit signal to activate or deactivate selected functions; electromechanical actuators that enable users to deploy power functions in a vehicle and to integrate switching and control functions; and other electronic products. Stoneridge was founded in 1965 and is headquartered in Warren, Ohio.
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE RESEARCH GROUP INC..
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com, which is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares at any given time.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
